Literature DB >> 10492370

A reverse flow-metabolism mismatch pattern on PET is related to multivessel disease in patients with acute myocardial infarction.

H Yamagishi1, K Akioka, K Hirata, Y Sakanoue, K Takeuchi, J Yoshikawa, H Ochi.   

Abstract

UNLABELLED: Hypoperfused myocardium with increased uptake of 18F-fluorodeoxyglucose (FDG) is considered to be ischemic but viable myocardium. However, the significance of a more severe defect of FDG than of 13N ammonia (NH3) (i.e., reverse flow-metabolism mismatch) is not well understood.
METHODS: To study a reverse flow-metabolism mismatch pattern, PET with NH3 and FDG under glucose loading was performed in 35 patients within 2 wk after onset of first acute myocardial infarction (AMI) and in 29 patients with old myocardial infarction (OMI). The left ventricle was divided into nine segments on a bull's eye polar map, and the mean counts of NH3 (%NH3) and FDG (%FDG) were compared for the segment with the least %NH3.
RESULTS: Ten patients in the AMI group demonstrated a marked reverse flow-metabolism mismatch pattern (greater than 10% difference between %NH3 and %FDG), whereas only 2 patients in the OMI group demonstrated the mismatch pattern (P < 0.05). Sixteen patients with AMI demonstrated %FDG > %NH3 (group 1), and 19 patients with AMI demonstrated %FDG < %NH3 (group 2). There were no significant differences in age, sex, location of infarction, diameter of stenosis of infarct-related artery or left ventricular ejection fraction between groups 1 and 2. Eleven patients in group 2 and only 3 in group 1 had multivessel disease (P < 0.02). There was no significant relationship between the number of diseased vessels and the flow-metabolism pattern in patients with OMI.
CONCLUSION: The finding of a reverse flow-metabolism mismatch on PET in the subacute phase of myocardial infarction was closely related to multivessel disease.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10492370

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  13 in total

Review 1.  PET radiopharmaceuticals used in viability studies in acute myocardial infarction: a literature survey.

Authors:  Liesbet Mesotten; Alex Maes; Frans Van de Werf; Luc Mortelmans
Journal:  Eur J Nucl Med Mol Imaging       Date:  2001-11-14       Impact factor: 9.236

2.  PET myocardial perfusion and glucose metabolism imaging: Part 2-Guidelines for interpretation and reporting.

Authors:  Heinrich R Schelbert; Robert Beanlands; Frank Bengel; Juhani Knuuti; Marcelo Dicarli; Josef Machac; Randolph Patterson
Journal:  J Nucl Cardiol       Date:  2003 Sep-Oct       Impact factor: 5.952

3.  Is having a sweetheart enough to survive?

Authors:  Samia Massalha; Riemer H J A Slart
Journal:  J Nucl Cardiol       Date:  2018-09-06       Impact factor: 5.952

4.  Altered myocardial glucose utilization and the reverse mismatch pattern on rubidium-82 perfusion/F-18-FDG PET during the sub-acute phase following reperfusion of acute anterior myocardial infarction.

Authors:  Daniel D Anselm; Anjali H Anselm; Jennifer Renaud; Harold L Atkins; Robert de Kemp; Ian G Burwash; Kathryn A Williams; Ann Guo; Cathy Kelly; Jean Dasilva; Rob S B Beanlands; Christopher A Glover
Journal:  J Nucl Cardiol       Date:  2011-05-13       Impact factor: 5.952

5.  Reverse blood flow-glucose metabolism mismatch indicates preserved oxygen metabolism in patients with revascularised myocardial infarction.

Authors:  Yoshitomo Fukuoka; Akira Nakano; Hiroyasu Uzui; Naoki Amaya; Kentaro Ishida; Kenichiro Arakawa; Takashi Kudo; Hidehiko Okazawa; Takanori Ueda; Jong-Dae Lee; Hiroshi Tada
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-04-27       Impact factor: 9.236

6.  Development of myocardial microcirculation and metabolism in acute ST-elevation myocardial infarction evaluated with positron emission tomography.

Authors:  Gunnar Frostfeldt; Jens Sörensen; Bertil Lindahl; Sven Valind; Lars Wallentin
Journal:  J Nucl Cardiol       Date:  2005 Jan-Feb       Impact factor: 5.952

7.  Use of 18F-FDG PET/CT texture analysis to diagnose cardiac sarcoidosis.

Authors:  Osamu Manabe; Hiroshi Ohira; Kenji Hirata; Souichiro Hayashi; Masanao Naya; Ichizo Tsujino; Tadao Aikawa; Kazuhiro Koyanagawa; Noriko Oyama-Manabe; Yuuki Tomiyama; Keiichi Magota; Keiichiro Yoshinaga; Nagara Tamaki
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-10-16       Impact factor: 9.236

8.  Acute impairment of regional myocardial glucose uptake in the apical ballooning (takotsubo) syndrome.

Authors:  Kevin A Bybee; Joseph Murphy; Abhiram Prasad; R Scott Wright; Amir Lerman; Charanjit S Rihal; Panithaya Chareonthaitawee
Journal:  J Nucl Cardiol       Date:  2006 Mar-Apr       Impact factor: 5.952

9.  Clinical significance of quantitative assessment of glucose utilization in patients with ischemic cardiomyopathy.

Authors:  Kuan-Yin Ko; Shan-Ying Wang; Ruoh-Fang Yen; Yu-Chien Shiau; Jung-Cheng Hsu; Hao-Yuan Tsai; Chien-Lin Lee; Kuan-Ming Chiu; Yen-Wen Wu
Journal:  J Nucl Cardiol       Date:  2018-08-14       Impact factor: 5.952

10.  Incidence of stunned, hibernating and scarred myocardium in ischaemic cardiomyopathy.

Authors:  Miguel Hernandez-Pampaloni; Jeroen J Bax; Koichi Morita; David P Dutka; Paolo G Camici
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-10-12       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.